Security file · CUSIP 37733W204
GSK
GSK PLC-SPON ADR · US listing · held by 5 tracked managers in Q3 2026.
Tracked holders · Q3 2026
5
-1 vs Q2 2026
Aggregate reported value
$2.10B
sum of holders' reported positions
New holders this quarter
0
1 added · 4 trimmed
Holder return since filing
+0.2%
weighted by each holder's position share · since filing
Ownership · Q3 2026
| Manager | Weight | Shares | Δ shares | Entry | Return | Value | Activity | |
|---|---|---|---|---|---|---|---|---|
| 1 | Dodge & Cox Fundsfiled 13 Nov ET | 1.12% | 43.18M | -10.4% | $50 | +0.9% | $2.08B | Trimmed |
| 2 | Kahn Brothers Groupfiled 16 Nov ET | 0.91% | 114K | -28.3% | $51 | +0.0% | $5.47M | Trimmed |
| 3 | Hillman Capital Managementfiled 16 Nov ET | 3.31% | 92K | -0.5% | $51 | +0.0% | $4.43M | Trimmed |
| 4 | Tweedy Brownefiled 04 Nov ET | 0.30% | 77K | -5.0% | $51 | +0.4% | $3.73M | Trimmed |
| 5 | Richard Pzena - Pzena Investment Managementfiled 30 Oct ET | 0.00% | 29K | +18.2% | $49 | +3.7% | $1.40M | Added |
Holder count
Aggregate reported value
Quarterly aggregation
| Quarter | Holders | Δ holders | Aggregate value | Total shares |
|---|---|---|---|---|
| Q3 2026 | 5 | -1 | $2.10B | 43.50M |
| Q2 2026 | 6 | +0 | $2.55B | 48.56M |
| Q1 2026 | 6 | +0 | $3.26B | 59.03M |
| Q4 2025 | 6 | +1 | $3.38B | 68.94M |
| Q3 2025 | 5 | +1 | $3.45B | 79.93M |
| Q2 2025 | 4 | +1 | $3.10B | 80.68M |
| Q1 2025 | 3 | +0 | $3.10B | 79.92M |
| Q4 2024 | 3 | +1 | $2.36B | 69.75M |
| Q3 2024 | 2 | +0 | $2.79B | 68.28M |
| Q2 2024 | 2 | +0 | $2.64B | 68.53M |
| Q1 2024 | 2 | +0 | $2.96B | 69.10M |
| Q4 2023 | 2 | -1 | $2.56B | 69.08M |
| Q3 2023 | 3 | +1 | $2.53B | 69.66M |
| Q2 2023 | 2 | — | $2.49B | 69.85M |